Humoral Immune Response of BNT162b2 and CoronaVac Vaccinations in Hemodialysis Patients: A Multicenter Prospective Cohort

The CoronaVac vaccine is the most used anti-SARS-CoV-2 vaccine worldwide. Previous data indicate that this vaccine produces a lower immune response than RNA vaccines such as BNT162b2. End-stage renal disease (ESRD) patients have an increased rate of COVID-19 and a reduced immune response to vaccinat...

Descripción completa

Detalles Bibliográficos
Autores principales: Clavero, Rene, Parra-Lucares, Alfredo, Méndez-Valdés, Gabriel, Villa, Eduardo, Bravo, Karin, Mondaca, Evelyn, Aranda, Josseline, Brignardello, Rose, Gajardo, Cynthia, Ordenes, Angelica, Colombo, Evelyn, Tapia, Jessica, Etcheverry, Andoni, Zúñiga, José, Toro, Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503801/
https://www.ncbi.nlm.nih.gov/pubmed/36146621
http://dx.doi.org/10.3390/vaccines10091542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503801/
https://www.ncbi.nlm.nih.gov/pubmed/36146621
http://dx.doi.org/10.3390/vaccines10091542

Ejemplares similares